First Time Loading...

Gilead Sciences Inc
NASDAQ:GILD

Watchlist Manager
Gilead Sciences Inc Logo
Gilead Sciences Inc
NASDAQ:GILD
Watchlist
Price: 66.5747 USD 1.77%
Updated: Apr 29, 2024
Section:
 

Relative Value

The Relative Value of one GILD stock under the Base Case scenario is 78.2024 USD. Compared to the current market price of 66.5747 USD, Gilead Sciences Inc is Undervalued by 15%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

GILD Relative Value
Base Case
78.2024 USD
Undervaluation 15%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3.1
P/S
P/S
Price to Sales
3.1
vs History
65
vs Industry
74
Median 3Y
3.1
Median 5Y
3.2
Industry
8.1
Forward
3
More Details
14.6
P/E
P/E
Price to Earnings
14.6
vs History
68
vs Industry
9
Median 3Y
17.2
Median 5Y
17
Industry
26.2
Forward
9.2
More Details
10.3
P/OCF
P/OCF
Price to OCF
10.3
vs History
22
vs Industry
11
Median 3Y
9.2
Median 5Y
8.7
Industry
22.6
More Details
12.7
P/FCFE
P/FCFE
Price to FCFE
12.7
vs History
60
vs Industry
9
Median 3Y
12.9
Median 5Y
13.4
Industry
21.3
More Details
3.6
P/B
P/B
Price to Book Value
3.6
vs History
77
vs Industry
27
Median 3Y
4
Median 5Y
3.9
Industry
2.5
More Details
3.5
EV/S
EV/S
Enterprise Value to Sales
3.5
vs History
61
vs Industry
60
Median 3Y
3.8
Median 5Y
3.7
Industry
7.3
Forward
3.4
More Details
4.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
4.5
vs History
61
vs Industry
58
Median 3Y
4.9
Median 5Y
4.6
Industry
9.1
More Details
8
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
8
vs History
76
vs Industry
11
Median 3Y
9.2
Median 5Y
10.1
Industry
4.4
Forward
8
More Details
10.3
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
10.3
vs History
65
vs Industry
9
Median 3Y
11.5
Median 5Y
12
Industry
4.3
Forward
9.2
More Details
11.9
EV/OCF
EV/OCF
Enterprise Value to OCF
11.9
vs History
22
vs Industry
11
Median 3Y
11.5
Median 5Y
9.8
Industry
5.4
More Details
12.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
12.8
vs History
22
vs Industry
8
Median 3Y
12.3
Median 5Y
10.5
Industry
3.2
More Details
1.8
EV/IC
EV/IC
Enterprise Value to IC
1.8
vs History
63
vs Industry
49
Median 3Y
1.7
Median 5Y
2
Industry
5
More Details

Multiples Across Competitors

GILD Competitors Multiples
Gilead Sciences Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Gilead Sciences Inc
NASDAQ:GILD
82.8B USD 3.1 14.6 8 10.3
US
Abbvie Inc
NYSE:ABBV
280.4B USD 5.2 58.2 12.7 19.3
US
Amgen Inc
NASDAQ:AMGN
146.3B USD 5.2 21.7 16.2 24.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
102.4B USD 10.3 28.2 22.6 23.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
97.9B USD 7.5 24.8 16.4 18
AU
CSL Ltd
ASX:CSL
132.9B AUD 6.1 35.1 21.3 26.4
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Moderna Inc
NASDAQ:MRNA
42.6B USD 6.2 -9 -9.6 -8.2
US
Biogen Inc
NASDAQ:BIIB
31.6B USD 3.2 27.2 14.7 18.2
IE
Horizon Therapeutics PLC
NASDAQ:HZNP
26.6B USD 7.3 60.8 27.9 47
KR
Celltrion Inc
KRX:068270
38.1T KRW 17.5 71.1 41.9 57.7

See Also

Summary
GILD intrinsic value, competitors valuation, and company profile.
DCF Valuation
GILD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GILD stock valuation using valuation multiples.
Wall Street Estimates
GILD price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GILD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 132,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.